FrancophonIA/ELRC3.0 huggingface dataset:
English: A randomised study assessed the clinical efficacy response rate in DMARD-naïve patients (n = 121) with early RA, who received either 20 mg or 100 mg of leflunomide in two parallel groups during the initial three day double blind period.
Croatian: Bolesnici su podijeljeni u dvije paralelne skupine i dobivali su ili 20 mg ili 100 mg leflunomida tijekom prva tri dana dvostruko slijepog ispitivanja.
English: diarrhoea, nausea, vomiting, oral mucosal disorders (e.g., aphthous stomatitis, mouth ulceration), abdominal pain; colitis including microscopic colitis such as lymphocytic colitis, collagenous colitis
Croatian: proljev, mučnina, povraćanje, poremećaji sluznice usne šupljine (npr. aftozni stomatitis, ulceracije u ustima), bol u trbuhu; kolitis, uključujući mikroskopski kolitis poput limfocitnog kolitisa, kolagenog kolitisa Manje često: poremećaji okusa
English: 3°years
Croatian: 6.3 Rok valjanosti
English: (pancytopenia), - severe increase in blood pressure, - inflammation of the lung (interstitial lung disease), - an increase in some liver results which may develop into serious conditions such as hepatitis and jaundice, - severe infections called sepsis which may be fatal, - an increase of certain enzymes in the blood (lactate dehydrogenase).
Croatian: Rijetke nuspojave (mogu se javiti u do 1 na 1000 ljudi): - povećanje broja krvnih stanica koje se zovu eozinofili (eozinofilija); blago smanjenje broja bijelih krvnih stanica (leukopenija); smanjenje broja svih krvnih stanica (pancitopenija), - izraziti porast krvnog tlaka, - upala pluća (intersticijska plućna bolest), - povećanje rezultata u rezultatima nekih jetrenih testova što se može razviti u ozbiljna stanja poput hepatitisa i žutice, - teške infekcije, uključujući sepsu, koje mogu biti dovesti do smrtnog ishoda, - povećanje enzima laktat dehidrogenaze u krvi.
English: Tablet 30 tablets 100 tablets
Croatian: Tableta 30 tableta 100 tableta NAČIN I PUT(EVI) PRIMJENE LIJEKA Kroz usta.
English: Reproductive system and breast disorders Not known:
Croatian: Poremećaji reproduktivnog sustava i dojki
English: - a slight decrease in the number of white blood cells (leucopenia), - mild allergic reactions, - loss of appetite, weight loss (usually insignificant), - tiredness (asthenia), - headache, dizziness, - abnormal skin sensations like tingling (paraesthesia), - mild increase in blood pressure,
Croatian: Česte nuspojave (mogu se javiti u do 1 na 10 ljudi) - blago smanjeni broj bijelih krvnih stanica (leukopenija), - blaže alergijske reakcije, - gubitak apetita, gubitak težine (obično beznačajan), - umor (astenija), - glavobolja, omaglica,
English: Pregnancy must be excluded before start of treatment with leflunomide,
Croatian: Prije liječenja leflunomidom mora se isključiti trudnoća
English: Alanine aminotransferase (ALT) or serum glutamopyruvate transferase (SGPT) and a complete blood cell count, including a differential white blood cell count and a platelet count, must be checked simultaneously and with the same frequency: before initiation of leflunomide, every two weeks during the first six months of treatment, and every 8 weeks thereafter (see section 4.4).
Croatian: Alanin aminotransferazu (ALT) ili serumsku glutamopiruvat transferazu (SGPT) i kompletnu krvnu sliku, uključujući diferencijalnu bijelu krvnu sliku i broj trombocita, mora se provjeravati istodobno i u jednakim intervalima:
English: How to store Leflunomide ratiopharm
Croatian: Kako čuvati Leflunomid ratiopharm
English: How to take Leflunomide ratiopharm
Croatian: Kako uzimati Leflunomid ratiopharm
English: In this trial, the loading dose and maintenance dose of leflunomide was based on three weight categories: <20 kg, 20-40 kg, and >40 kg. After 16 weeks treatment, the difference in response rates was statistically significant in favour of methotrexate for the JRA Definition of Improvement (DOI) ≥30% (p=0.02).
Croatian: U ovom su se ispitivanju udarna doza i doza održavanja leflunomida zasnivale na 3 kategorije tjelesne težine: <20 kg, 20-40 kg i >40 kg.
English: ratiopharm GmbH
Croatian: NOSITELJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET ratiopharm GmbH
English: - a marked decrease of some white blood cells (agranulocytosis), - severe and potentially severe allergic reactions, - inflammation of the small vessels (vasculitis, including cutaneous necrotizing vasculitis), - inflammation of the pancreas (pancreatitis), - severe liver injury such as liver failure or necrosis which may be fatal,
Croatian: Vrlo rijetke nuspojave (mogu se javiti u do 1 na 10 000 ljudi) - izrazito smanjenje broja pojedinih bijelih krvnih stanica (agranulocitoza), - teške i potencijalno teške alergijske reakcije, - upala malih krvnih žila (vaskulitis, uključujući kožni nekrotizirajući vaskulitis), - upala gušterače (pankreatitis), - teške ozljede jetre kao što su zatajenje jetre ili nekroza koje mogu završiti i smrtnim ishodom, - teške i ponekad po život opasne reakcije (Stevens-Johnsonov sindrom, toksična epidermalna nekroliza, multiformni eritem).
English: Leflunomide ratiopharm 20 mg film-coated tablets Leflunomide
Croatian: Leflunomid ratiopharm 20 mg filmom obložene tablete leflunomid
English: Leflunomide ratiopharm 10 mg film-coated tablets Leflunomide
Croatian: Leflunomid ratiopharm 10 mg filmom obložene tablete leflunomid
English: The extent of leflunomide absorption is not affected if it is taken with food.
Croatian: Istodobno uzimanje s hranom ne ometa opseg apsorpcije leflunomida.
English: Leflunomide ratiopharm 10 mg tablets Leflunomide
Croatian: NAZIV LIJEKA Leflunomid ratiopharm 10 mg tablete leflunomid NAVOĐENJE DJELATNE/IH
English: Tablet core
Croatian: zatajenje bubrega
English: Leflunomide ratiopharm 20 mg tablets Leflunomide
Croatian: NAZIV LIJEKA Leflunomid ratiopharm 20 mg tablete leflunomid NAVOĐENJE DJELATNE/IH
English: Leflunomide ratiopharm 10 mg film-coated tablets
Croatian: NAZIV LIJEKA Leflunomid ratiopharm 10 mg filmom obložene tablete
English: - if you are male and wish to father a child. As it can not be excluded that Leflunomide ratiopharm passes into semen, reliable contraception should be used during treatment with Leflunomide ratiopharm.
Croatian: Budući da se ne može isključiti izlučivanje Leflunomida ratiopharm u spermu, tijekom terapije Leflunomidom ratiopharm treba primjenjivati učinkovitu kontracepciju.
English: agranulocytosis
Croatian: Vrlo rijetko: agranulocitoza
English: Leflunomide ratiopharm 20 mg film-coated tablets
Croatian: NAZIV LIJEKA Leflunomid ratiopharm 20 mg filmom obložene tablete
English: - an increase in the numbers of blood cells called eosinophiles (eosinophilia); mild decrease in the number of white blood cells (leucopenia); decrease in the number of all blood cells
Croatian: Manje česte nuspojave (mogu se javiti u do 1 na 100 ljudi) - smanjeni broj crvenih krvnih stanica (anemija) i smanjenje broja krvnih pločica
English: United Kingdom Teva Uk Limited
Croatian: Teva Uk Limited
English: Fish Oil 0.5ml/Ml
Croatian: Riblje ulje 0,5ml/Ml
English: Omega-3-Acid Ethyl Esters 90 With A Specific Composition For Epa And Dha Not Lower Than 85%.
Croatian: Etil esteri omega-3 kiseline 90 s posebnim sastavom za Epa i Dha koji nije niži od 85 %.
English: 500mg Capsule
Croatian: 500mg kapsula
English: Fish Oil 1000mg Capsule
Croatian: Riblje ulje 1000mg kapsula
English: 1000mg Capsule
Croatian: 1000mg kapsula
English: United Kingdom Mercury Pharmaceuticals Ltd.
Croatian: Mercury Pharmaceuticals Ltd.
English: Esters Of Unsaturated Fatty Acids 500mg Capsule
Croatian: Esteri nezasićenih masnih kiselina 500mg kapsula
English: Ratiopharm Gmbh Omega-3 Ratiopharm Omega-3-Acid Ethyl Esters 90 1000mg
Croatian: Ratiopharm Gmbh Omega-3 Ratiopharm Etil esteri omega-3 kiseline 90 1000mg kapsula
English: Triglycerides Medium Chain 1qs Capsule, Lecithin Soya 1qs Capsule, Omega-3-Acid Ethyl Esters 90 1000mg Capsule
Croatian: Srednji lanac triglicerida 1qs kapsula, sojin lecitin 1qs kapsula, etil esteri omega-3 kiseline 90
English: Omega-3 Fatty Acids 1000mg Capsule
Croatian: Omega-3 masne kiseline 1000mg kapsula
English: Oral Emulsion
Croatian: Oralna emulzija
English: Esters Of Unsaturated Fatty Acids 1000mg Capsule
Croatian: Esteri nezasićenih masnih kiselina 1000mg kapsula
English: Ácidos Omega 3 Aristo Omega-3-Acid Ethyl Esters 1000mg Capsule
Croatian: Ácidos Omega 3 Aristo Etil esteri omega-3 kiseline 1000mg kapsula
English: Eicosapentaenoic Acid 791mg/5ml, Vitamin A 100 I.U.G
Croatian: I.U./G.,eikosapentenoič na kiselina 791mg/5ml, Vitamin A 100 I.U./G.
English: Docosahexaenoic Acid 265mg/5ml, Eicosapentaenoic Acid 390mg/5ml
Croatian: Dokosaheksanoična kiselina 265mg/5ml, eikosapentenoična kiselina 390mg/5ml
English: Docosahexaenoic Acid 115mg Capsule, Vitamin D 1 I.U.G,
Croatian: Dokosaheksanoična kiselina 115mg kapsula, Vitamin D 1
English: Eicosapentaenoic Acid 170mg Capsule, Vitamin A 1 I.U.G
Croatian: I.U./G.,eikosapentenoič na kiselina 170mg kapsula, Vitamin A 1 I.U./G.
English: Docosahexaenoic Acid 115mg Capsule, Eicosapentanoic Acid/Docosahexaenoic Acid 170mg Capsule
Croatian: Dokosaheksanoična kiselina 115mg kapsula, eikosapentenoična kiselina/dokosaheksanoi čna kiselina 170mg kapsula
English: Docosahexaenoic Acid 527mg/5ml, Vitamin D 10 I.U.G,
Croatian: Dokosaheksanoična kiselina 527mg/5ml, Vitamin D 10
English: Docosahexaenoic Acid 60mg Capsule, Eicosapentaenoic Acid 90mg Capsule
Croatian: Dokosaheksanoična kiselina 60mg kapsula, eikosapentenoična kiselina 90mg kapsula
English: Acidos Omega 3 Stada Omega-3-Acid Ethyl Esters 90 1000mg
Croatian: Acidos Omega 3 Stada Etil esteri omega-3 kiseline 90 1000mg kapsula
English: Docosahexaenoic Acid 120mg Capsule, Eicosapentaenoic Acid 180mg Capsule
Croatian: Dokosaheksanoična kiselina 120mg kapsula, eikosapentenoična kiselina 180mg kapsula
English: Docosahexaenoic Acid 527mg/5ml, Eicosapentanoic Acid/Docosahexaenoic Acid 791mg/5ml
Croatian: Dokosaheksanoična kiselina 527mg/5ml, eikosapentenoična kiselina/dokosaheksanoi čna kiselina 791mg/5ml
English: Docosahexaenoic Acid 527mg/5ml, Eicosapentaenoic Acid 791mg/5ml
Croatian: Dokosaheksanoična kiselina 527mg/5ml, eikosapentenoična kiselina 791mg/5ml
English: Docosahexaenoic Acid Ethyl Ester 437mg Capsule
Croatian: Etil ester eikosapentenoične kiseline 430mg kapsula, etil ester dokosaheksanoične kiseline 437mg kapsula
English: Docosahexaenoic Acid 115mg Capsule, Eicosapentaenoic Acid 170mg Capsule
Croatian: Dokosaheksanoična kiselina 115mg kapsula, eikosapentenoična kiselina 170mg kapsula
English: Docosahexaenoic Acid Ethyl Ester 380mg Capsule
Croatian: Etil ester eikosapentenoične kiseline 460mg kapsula, etil ester dokosaheksanoične kiseline 380mg kapsula
English: Ácidos Omega 3 Tarbis Docosahexaenoic Acid 380mg Capsule,
Croatian: Ácidos Omega 3 Tarbis Dokosaheksanoična kiselina 380mg kapsula, eikosapentenoična kiselina 460mg kapsula, etil esteri omega-3 kiseline 90 1000mg tableta
English: Eicosapentaenoic Acid 170mg Capsule, Vitamin A 100 I.U.G
Croatian: Dokosaheksanoična kiselina 115mg kapsula, Vitamin D 10 I.U./G., eikosapentenoična kiselina 170mg kapsula, Vitamin A 100 I.U./G.
English: Eicosapentaenoic Acid
Croatian: Oralna otopina
English: Pharmaceutical Form Route of administration
Croatian: Farmaceutski oblik
English: This summary was last updated in 11-2016.
Croatian: Ovaj sažetak posljednji je put ažuriran u 11.2016.
English: This dose may need to be increased after one or two weeks to up to 45 mg once a day if better blood glucose (sugar) control is needed.
Croatian: Tu će dozu možda trebati povećati nakon jednoga ili dva tjedna do 45 mg jednom dnevno ako je potrebna veća kontrola glukoze u krvi (šećera).
English: The full EPAR for Pioglitazone Actavis can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Croatian: Cjeloviti EPAR za lijek Pioglitazone Actavis nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: This means that Pioglitazone Actavis is similar to a ‘reference medicine' already authorised in the European Union (EU) called Actos.
Croatian: To znači da je Pioglitazone Actavis sličan „referentnom lijeku” koji je već odobren u Europskoj uniji (EU) pod nazivom Actos.
English: As a consequence, the blood glucose levels are reduced and this helps to control type 2 diabetes.
Croatian: Posljedica je smanjenje razine glukoze u krvi, što pomaže u kontroli dijabetesa tipa 2.
English: At subsequent reviews prescribers should confirm that benefits to patients are maintained.
Croatian: U naknadnim procjenama liječnici koji propisuju terapiju trebali bi potvrditi da i dalje postoje koristi za bolesnike.
English: The active substance in Pioglitazone Actavis, pioglitazone, makes cells (fat, muscle and liver) more sensitive to insulin, which means that the body makes better use of the insulin it produces.
Croatian: Djelatna tvar u lijeku Pioglitazone Actavis, pioglitazon, čini stanice (masti, mišića i jetre) osjetljivijima na inzulin, što znači da tijelo bolje iskorištava inzulin koji proizvodi.
English: Pioglitazone Actavis is used to treat type 2 diabetes in adults (aged 18 years or over), particularly those who are overweight.
Croatian: Lijek Pioglitazone Actavis primjenjuje se za liječenje dijabetesa tipa 2 u odraslih osoba (u dobi od 18 godina ili starijih), osobito u onih prekomjerne tjelesne težine.
English: The company that markets Pioglitazone Actavis will produce educational material for doctors prescribing the medicine, which will cover the possible risk of heart failure and bladder cancer with treatments that contain pioglitazone, the criteria for selecting patients and the need to review treatment regularly and stop treatment if patients are no longer benefiting.
Croatian: Tvrtka koja lijek Pioglitazone Actavis stavlja u promet osigurat će edukativni materijal za liječnike koji propisuju taj lijek koji će sadržavati informacije o mogućem riziku od srčanog zastoja i raka mjehura u liječenjima koja sadrže pioglitazon, kriterije za odabir bolesnika i potrebu za redovitim procjenjivanjem učinaka terapije i prekidom liječenja ako bolesnici više nemaju koristi od njega.
English: Pioglitazone Actavis
Croatian: Pioglitazone Actavis pioglitazon
English: The European Commission granted a marketing authorisation valid throughout the European Union for Pioglitazone Actavis on 15 March 2012.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za lijek Pioglitazone Actavis na snazi u Europskoj uniji od 15. ožujka 2012.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Pioglitazone Actavis has been shown to have comparable quality and to be bioequivalent to Actos.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) pri Agenciji zaključio je kako je, u skladu sa zahtjevima EU-a, Pioglitazone Actavis dokazao usporedivu kakvoću te da je bioekvivalentan lijeku Actos.
English: This is a summary of the European public assessment report (EPAR) for Pioglitazone Actavis.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) lijeka Pioglitazone Actavis.
English: Pioglitazone Actavis is a ‘generic medicine'.
Croatian: Pioglitazone Actavis je „generički lijek”.
English: What measures are being taken to ensure the safe and effective use of Pioglitazone Actavis?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Pioglitazone Actavis?
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Pioglitazone Actavis have also been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Pioglitazone Actavis nalaze se također u sažetku opisa svojstava lijeka i u uputi o lijeku.
English: Treatment with Pioglitazone Actavis should be reviewed after three to six months, and discontinued in patients who are not deriving sufficient benefit.
Croatian: Nakon tri do šest mjeseci liječenja lijekom Pioglitazone Actavis potrebno je procijeniti liječenje i prekinuti ga u bolesnika u kojih nisu vidljive dostatne koristi.
English: What is Pioglitazone Actavis and what is it used for?
Croatian: Što je Pioglitazone Actavis i za što se koristi?
English: Because Pioglitazone Actavis is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Croatian: Budući da je lijek Pioglitazone Actavis generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i kod referentnog lijeka.
English: For more information about treatment with Pioglitazone Actavis, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Pioglitazone Actavis pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svom liječniku ili ljekarniku.
English: Other information about Pioglitazone Actavis
Croatian: Ostale informacije o lijeku Pioglitazone Actavis
English: It is not intended to provide practical advice on how to use Pioglitazone Actavis.
Croatian: Svrha sažetka nije davati praktične savjete o primjeni lijeka Pioglitazone Actavis.
English: • together with insulin in patients who are not satisfactorily controlled with insulin alone and cannot take metformin.
Croatian: • zajedno s inzulinom u bolesnika u kojih se ne može postići zadovoljavajuća kontrola samo inzulinom i koji ne mogu uzimati metformin.
English: • together with both metformin and a sulphonylurea in patients who are not satisfactorily controlled despite treatment with two medicines by mouth;
Croatian: • zajedno s metforminom i sulfonilurejom u bolesnika u kojih se ne može postići zadovoljavajuća kontrola unatoč terapiji dvama lijekovima oralnom primjenom;
English: The Committee recommended that Pioglitazone Actavis be approved for use in the EU.
Croatian: Odbor je preporučio izdavanje odobrenja za stavljanje u promet lijeka Pioglitazone Actavis u EU-u.
English: What are the benefits and risks of Pioglitazone Actavis?
Croatian: Koje su koristi i rizici primjene lijeka Pioglitazone Actavis?
English: • in combination with metformin in patients who are not satisfactorily controlled on metformin alone, or with a sulphonylurea (another type of diabetes medicine) when metformin is not suitable in patients who are not satisfactorily controlled on a sulphonylurea alone;
Croatian: • u kombinaciji s metforminom u bolesnika u kojih se ne može postići zadovoljavajuća kontrola metforminom kao monoterapijom ili sa sulfonilurejom (drugom vrstom lijeka protiv dijabetesa) ako metformin nije prikladan u bolesnika u kojih se ne može postići zadovoljavajuća kontrola sulfonilurejom kao monoterapijom;
English: Why is Pioglitazone Actavis approved?
Croatian: Zašto je Pioglitazone Actavis odobren?
English: Because Pioglitazone Actavis is a generic medicine, studies in patients have been limited to tests to determine that it is bioequivalent to the reference medicine, Actos.
Croatian: Budući da je lijek Pioglitazone Actavis generički lijek, ispitivanja na bolesnicima bila su ograničena na ispitivanja za utvrđivanje bioekvivalentnosti s referentnim lijekom Actos.
English: Pioglitazone Actavis contains the active substance pioglitazone.
Croatian: Pioglitazone Actavis sadrži djelatnu tvar pioglitazon.
English: For practical information about using Pioglitazone Actavis, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o primjeni lijeka Pioglitazone Actavis bolesnici trebaju pročitati u uputi o lijeku, odnosno obratiti se svom liječniku ili ljekarniku.
English: Therefore, the CHMP's view was that, as for Actos, the benefit outweighs the identified risk.
Croatian: Stoga je stav CHMP-a bio da koristi nadmašuju utvrđene rizike, kao i za lijek Actos.
English: Pioglitazone Actavis can only be obtained with a prescription.
Croatian: Pioglitazone Actavis izdaje se samo na liječnički recept.
English: How does Pioglitazone Actavis work?
Croatian: Kako djeluje Pioglitazone Actavis?
English: How is Pioglitazone Actavis used?
Croatian: Kako se Pioglitazone Actavis koristi?
English: How has Pioglitazone Actavis been studied?
Croatian: Kako je Pioglitazone Actavis ispitivan?
English: - if you are more than 3 months pregnant.
Croatian: - ako ste trudni više od 3 mjeseca.
English: [Actavis logo]
Croatian: [logo Actavis]
English: Take it as soon as you remember, then carry on as before.
Croatian: Uzmite je čim se sjetite, a zatim nastavite kao i ranije.
English: If you forget to take a dose, do not worry.
Croatian: Ako zaboravite uzeti jednu dozu, ne brinite se.
English: It is important that you take Actelsar HCT every day until your doctor tells you otherwise.
Croatian: Važno je da uzimate Actelsar HCT svaki dan dok Vam liječnik ne propiše drugačije.
English: Elderly Pharmacokinetics of telmisartan do not differ between the elderly and those younger than 65 years.
Croatian: Farmakokinetika telmisartana ne razlikuje se između starijih osoba i osoba mlađih od 65 godina.
English: (It is also better to avoid Actelsar HCT in early pregnancy - see pregnancy section).
Croatian: (Također je bolje izbjegavati Actelsar HCT u ranoj trudnoći pogledajte dio o trudnoći).
English: Actelsar HCT with food and alcohol
Croatian: Actelsar HCT s hranom i alkoholom
English: Your doctor may need to change the dose of these other medicines or take other precautions.
Croatian: Liječnik će Vam možda trebati promijeniti doziranje tih drugih lijekova ili poduzeti druge mjere opreza.
English: - Systemic lupus erythematosus (also called “lupus” or “SLE”) a disease where the body's immune system attacks the body.
Croatian: - sistemski lupus eritematozus (također zvan «lupus» ili «SLE»), bolest u kojoj imunološki sustav napada tijelo.
English: - Second and third trimesters of pregnancy (see sections 4.4 and 4.6).
Croatian: - Drugo i treće tromjesečje trudnoće (vidjeti dijelove 4.4 i 4.6 ).
English: Contact your doctor, pharmacist, or your nearest hospital emergency department immediately.
Croatian: Obavijestite liječnika ili ljekarnika ili se odmah javite u hitnu službu najbliže bolnice.
English: *The event may have happened by chance or could be related to a mechanism currently not known.
Croatian: * Do događaja je moglo doći slučajno ili je mogao biti povezan s trenutno nepoznatim mehanizmom.
English: - Raised aldosterone levels (water and salt retention in the body along with imbalance of various blood minerals).
Croatian: - giht. - povišene vrijednosti aldosterona (zadržavanje soli i vode u tijelu zajedno s neravnotežom raznih minerala u krvi).
English: The terminal elimination half-life of hydrochlorothiazide is 10-15 hours.
Croatian: Poluvrijeme eliminacije hidroklorotiazida je 10-15 sati.
English: The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines web-portal.
Croatian: Zahtjevi za podnošenje periodičkih izvješća o neškodljivosti za ovaj lijek definirani su u referentnom popisu datuma EU (EURD popis) predviđenom člankom 107.c stavkom 7. Direktive 2001/83/EZ i objavljeni na europskom internetskom portalu za lijekove.
English: Renal clearance is about 250-300 ml/min.
Croatian: Renalni klirens je oko 250-300 ml/min.
English: - Medicines to increase blood pressure, such as noradrenaline.
Croatian: - lijekovi za povišenje krvnog tlaka kao što je noradrenalin.
English: - Calcium supplements and/or vitamin D supplements.
Croatian: - nadomjesci kalcija i/ili nadomjesci vitamina D.
English: This applies especially to the medicines listed below taken at the same time with Actelsar HCT:
Croatian: Ovo se osobito odnosi na lijekove navedene u nastavku koji se uzimaju istodobno uz Actelsar HCT:
English: - Lithium containing medicines to treat some types of depression.
Croatian: - lijekovi koji sadrže litij za liječenje određenih oblika depresije.